A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer

NCT06526624 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Limited-stage Small-cell Lung Cancer

Interventions

DRUG: HS-20093

Sponsor

Hansoh BioMedical R&D Company